Safety issues in the treatment of paediatric supraventricular tachycardias

Drug Safety

Volumn 18, Issue 5, 1998, Pages 345-356

  Pfammatter, Jean Pierre ^a   Bauersfeld, Urs ^b  

^a CH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FLECAINIDE; NADOLOL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL DERIVATIVE; SOTALOL; VERAPAMIL;

ARTICLE; BOLUS INJECTION; BRONCHOSPASM; CARDIOVERSION; CATHETER ABLATION; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FLUSHING; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; PROPHYLAXIS; SHOCK; THORAX PAIN; WOLFF PARKINSON WHITE SYNDROME;

ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0031925718     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199818050-00004     Document Type: Article

References (82)

1. Garson A, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment and long-term follow-up in 217 patients. J Pediatr 1981; 98: 875-82
2. Perry JC, Garson A. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 1990; 16: 1215-20
3. Pfammatter JP, Paul T, Lehmann C, et al. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 1995; 26: 1002-7
4. Fish FA, Gillette PC, Benson VD. Proarrhythmia, cardiac arrest and sudden death in young patients receiving encainide and flecainide. J Am Coll Cardiol 1991; 18: 356-65
5. Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanism and their age distribution in pediatric patients. Am J Cardiol 1992; 69: 1028-32
6. Overholt ED, Rheuban KS, Gutgesell HP, et al. Usefulness of adenosine for arrhythmias in infants and children. Am J Cardiol 1988; 61: 336-40
7. Till J, Shinebourne EA, Rigby ML, et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J 1989; 62: 204-11
8. Pfammatter JP, Paul T, Bachmann D, et al. Efficacy and diagnostic use of adenosine in infants and children. Z Kardiol 1995; 84: 243-9
9. Paul T, Pfammatter JP. Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 1997; 18: 118-26
10. De Groff CG, Silka MJ. Bronchospasm after intravenous administration of adenosine in a patient with asthma. J Pediatr 1994; 125: 822-3
11. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991; 325: 1621-9
12. Kipel G, Rossi AF, Steinberg LG, et al. Malignant wide complex tachycardia after adenosine administration to a postoperative pediatric patient with congenital heart disease. Pediatr Cardiol 1995; 16: 36-7
13. Romer M, Candinas R. Adenosine-induced non-sustained polymorphic ventricular tachycardia. Eur Heart J 1994; 15: 281-2
14. Porter CJ, Garson A, Gillette FC. Verapamil: an effective calcium blocking agent for pediatric patients. Pediatrics 1983; 71: 748-55
15. Shahar E, Barzilay Z, Frand M. Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children. J Pediatr 1981; 98: 323-6
16. Greco R, Musto B, Arienzo V. Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, ATP and verapamil: a comparative study. Circulation 1982; 66: 504-8
17. Epstein ML, Kiel EA, Victoria BE. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 1985; 75: 737-40
18. Radford D. Side effects of verapamil in infants. Arch Dis Child 1983; 58: 465-6
19. Rankin AC, Rae AP, Cobbe SM. Misuse of intravenous verapamil in patients with ventricular tachycardia. Lancet 1987; II: 472-3
20. Griffith MJ, Ward DE, Linker NJ, et al. Adenosine in the diagnosis of broad complex tachycardia. Lancet 1988; I: 672-5
21. Reimer A, Paul T, Kallfelz HC. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac arrhythmias. Am J Cardiol 1991; 68: 741-4
22. Vignati G, Mauri L, Figini A. The use of propafenone in the treatment of tachydysrhythmias in children. Eur Heart J 1993; 14: 546-50
23. Weber H, Eigster G, Wesselhoeft H. Propafenone in the treatment of dysrhythmias in infants and children. Monatsschr Kinderheilk 1981; 129: 410-3
24. Paul T, Janousek J. New antiarrhythmic drugs in pediatric use: propafenone. Pediatr Cardiol 1994; 15: 190-7
25. Musto B, Onofrio A, Cavallaro C, et al. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. Am J Cardiol 1988; 62: 229-33
26. Ward DE, Jones S, Shinebourne EA. Use of flecainide acetate for refractory junctional tachycardias in children with the Wolff-Parkinson-White syndrome. Am J Cardiol 1986; 57: 787-90
27. Till JA, Rowland E, Shinebourne EA, et al. Treatment of refractory supraventricular arrhythmias with flecainide acetate. Arch Dis Child 1987; 62: 247-52
28. Wren C, Campell RW. The response of pediatric arrhythmias to intravenous and oral flecainide. Br Heart J 1987; 57: 171-5
29. Schneeweiss A. New antiarrhythmic drugs: flecainide. Pediatr Cardiol 1990; 11: 143-27
30. Benson DW, Dunnigan A, Green TP, et al. Periodic procainamide for paroxysmal tachycardia. Circulation 1985; 72: 147-52
31. Till JA, Shinebourne EA. Supraventricular tachycardia: diagnosis and current acute management. Arch Dis Child 1991; 66: 647-52
32. Jordaens L, Gorgels A, Stroobandt R, et al. Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia. Am J Cardiol 1991; 68: 35-40
33. Pfammatter JP, Paul T. New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol 1997; 18: 28-34
34. Perry JC, Fenrich AL, Hulse JE, et al. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol 1996; 27: 1246-50
35. Paul T, Guccione P. New antiarrhythmic drug in pediatric use: amiodarone. Pediatr Cardiol 1994; 15: 132-8
36. Sreeram N, Wren C. Supraventricular tachycardia in infants: response to initial treatment. Arch Dis Child 1990; 65: 127-9
37. Deal BJ, Keane JF, Gillette PC, et al. WPW-syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985; 5: 130-5
38. Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996; 131: 66-72
39. O'Sullivan JJ, Gardiner HM, Wren C. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants. J Am Coll Cardiol 1995; 26: 991-4
40. Pfammatter JP, Stocker FP. Role of digoxin in the oral long term treatment of supraventricular tachycardia in infancy. Eur J Pediatr 1998; 157: 101-6
41. Benson DW, Dunnigan A, Benditt DG, et al. Prediction of digoxin treatment failure in infants with supraventricular tachycardia: role of transoesophageal pacing. Pediatrics 1985; 75: 288-93
42. Byrum CJ, Wahl RA, Behrenct DM, et al. Ventricular fibrillation associated with use of digitalis in a newborn with WPW-syndrome. J Pediatr 1982; 101: 400-3
43. Mehta AV, Balasubrahmanyam C. Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children. J Am Coll Cardiol 1992; 19: 630-5
44. Trippel DL, Gillette PC. Atenolol in children with supraventricular tachycardia. Am J Cardiol 1989; 64: 233-6
45. Mehta AV, Subrahmanyan AE, Anand R. Long-term efficacy and safety of atenolol for supraventricular tachycardia in children. Pediatr Cardiol 1996; 17: 231-6
46. Lemler MS, Schaffer MS. Neonatal supraventricular tachycardia: predictors of successful treatment withdrawal. Am Heart J 1997; 133: 130-1
47. Janousek J, Paul T, Reimer A, et al. Usefulness of propafenone for supraventricular arrhythmias in infants and children. Am J Cardiol 1993; 72: 294-300
48. Maragnes P, Tipple M, Fournier A. Effectiveness of oral sotulol for treatment of pediatric dysrhythmias. Am J Cardiol 1992; 69: 751-4
49. Tipple M, Sandor G. Efficacy and safety of oral sotalol in early infancy. PACE 1991; 14; 2062-5
50. Kugler JD, Danford DA. Management of infants, children and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996; 129: 324-38
51. Guccione P, Paul T, Garson A. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 1990; 15: 1118-24
52. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: 135 cases. Am Heart J 1980; 100: 1063-9
53. Garson A, Gillette PC, McVey P, et al. Amiodarone treatment of critical arrhythmias in children and young adults. J Am Coll Cardiol 1984; 4: 749-55
54. Bucknall CA, Keeton BR, Curry PVL, et al. Intravenous and oral amiodarone for arrhythmias in children. Br Heart J 1986; 56: 278-84
55. Villain E, Bonnet D, Iserin P, et al. Current management of reentrant supraventricular tachycardia in infants [abstract]. Eur Heart J 1997; 18 Suppl.: 476
56. Garson A. Dosing the newer antiarrhythmic drugs in children: consideration in pediatric pharmacology. Am J Cardiol 1986; 57: 1405-7
57. Schaffer MS, Silka MJ, Ross BA, et al. Inadvertent atrioventricular block during radiofrequency catheter ablation. Circulation 1996; 94: 3214-20
58. Kugler JD, Danford DA, Ceal BJ, et al. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. N Engl J Med 1994; 330: 1481-7
59. Johnson TB, Varney FL, Gillette PC, et al. Lack of proarrhythmia as assessed by Holter monitor after atrial radio frequency ablation of supraventricular tachycardia in children. Am Heart J 1996; 132: 120-4
60. Kugler JD. Radiofrequency catheter ablation for supraventricular tachycardia: should it be used in infants and small children? Circulation 1994; 90: 639-41
61. Van Hare GF. Indications for radiofrequency ablation in the pediatric population. J Cardiovasc Electrophysiol 1997; 8: 952-62
62. Saul JP, Hulse JE, Walsh EF. Late enlargement of radiofrequency lesions in infant lambs: implications for ablation procedures in small children. Circulation 1994; 90: 492-9
63. Paul T, Bokenkamp R, Mahnert B, et al. Coronary artery involvement early and late after radiofrequency current application in young pigs. Am Heart J 1997; 133: 436-40
64. Casey FA, McCrindle BW, Hamilton RM, et al. Neonatal atrial flutter: significant early morbidity and excellent long term prognosis. Am Heart J 1997; 133: 302-6
65. Till J, Wren C. Atrial flutter in the fetus and young infant: an association with accessory connections. Br Heart J 1992; 67: 80-3
66. Dunnisan A, Benson W, Benditt DG. Atrial flutter in infancy: diagnosis, clinical features and treatment. Pediatrics 1985; 75: 725-9
67. Villain E, Vetter VL, Garcia JM, et al. Evolving concepts in the management of congenital junctional ectopic tachycardia. Circulation 1990; 81: 1544-9
68. Paul T, Reimer A, Janousek J, et al. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia. J Am Coll Cardiol 1992; 20: 911-4
69. Gillette PC, Garson A, Porter CJ, et al. Junctional ectopic tachycardia: new proposed treatment by transcatheter His ablation. Am Heart J 1983; 106: 619-23
70. Ticho BS, Saul JP, Hulse E, et al. Variable location of accessory pathways associated with the permanent form of junctional reciprocating tachycardia and confirmation with radiofrequency ablation. Am J Cardiol 1992; 70: 1559-64
71. Dorostkar P, Dick M, Serwer G, et al. Clinical course of persistent junctional reciprocating tachycardia. PACE 1993; 16: 878
72. Smith RT, Gillette PC, Massumi A, et al. Transcatheter ablative techniques for treatment of the permanent form of junctional reciprocating tachycardia in young patients. J Am Coll Cardiol 1986; 8: 385-90
73. Von Bernuth G, Engelhardt W, Kramer HH, et al. Atrial automatic tachycardia in infancy and childhood. Eur Heart J 1992; 13: 1410-5
74. Dhala AA, Case CL, Gillette PC. Evolving strategies for managing atrial ectopic tachycardia in children. Am J Cardiol 1994; 74: 283-6
75. Naheed ZJ, Strasburger JF, Benson W, et al. Natural history and management strategies of automatic atrial tachycardia in children. Am J Cardiol 1995; 75: 405-7
76. Koike K, Hesslein PS, Finlay CD. Atrial automatic tachycardia in children. Am J Cardiol 1988; 61: 1127-30
77. Colloridi V, Perri C, Ventriglia F, et al. Oral sotalol in pediatric atrial ectopic tachycardia. Am Heart J 1992; 123: 254-6
78. Bauersfeld U, Gow RM, Hamilton RM, et al. Treatment of atrial ectopic tachycardia in infants < 6 months old. Am Heart J 1995; 129: 1145-8
79. Saul JP, Walsh EP, Triedmar JK. Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol 1995; 6: 1129-48
80. Walsh EP, Saul P, Hulse JE, et al. Transcatheter ablation of atrial ectopic tachycardia in young patients using radiofrequency current. Circulation 1992; 86: 1138-46
81. Fenrich AL, Perry JC, Freidman RA. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. J Am Coll Cardiol 1995; 25: 1195-8
82. Pongiglione G, Strasburger JF, Deal BJ, et al. Use of amiodarone for short-term and adjuvant therapy in young patients. Am J Cardiol 1991; 68: 603-8